Clinical Trial Monitoring with Precision

Navigating the path to Precision in every study.

At Precision for Medicine, our Clinical Trial Monitoring strategies blend the art of oversight with the capabilities of innovative technologies. With an unwavering commitment to patient safety, data integrity, and trial efficiency, we will enhance each phase of your clinical development journey. We transform challenges into milestones, guiding your journey to success with unmatched precision

Principles of Precision in Clinical Trial Monitoring

At Precision for Medicine, our Clinical Research Associates (CRAs) serve as the linchpin between trials and triumph. Grounded in a philosophy that intertwines the safety of patients with the sanctity of data, our CRAs embody a suite of principles to diligently advance your trial’s objectives. Through proactive site management, effective communication, and unwavering compliance, they ensure each monitored site resonates with the rigor and care that define Precision’s approach to clinical oversight. Our commitment extends beyond standard practices, nurturing a culture of training and mentorship to foster growth and excellence in clinical monitoring.

Patient Safety First

Our CRAs prioritize patient well-being, meticulously monitoring safety protocols and ensuring prompt reporting of adverse events to safeguard participants.
Proactive Site Management

Vigilant and forward-thinking, our CRAs embrace site responsibility, preemptively addressing risks and streamlining solutions for challenges ahead
Effective Communication

Timely dissemination of site updates and swift report filing keep all stakeholders informed and engaged with the latest trial developments.
Compliance & Protocol Adherence

With a rigorous commitment to GCP and regulatory standards, our CRAs ensure protocol fidelity and comprehensive documentation integrity.
Training & Mentorship

We invest in continuous training and mentorship to empower our CRAs with the expertise and confidence to excel in the field.
Data Integrity Focus

The cornerstone of our mission is to safeguard the precision and integrity of study data, fueling reliable outcomes and decisive insights.

Precision in Clinical Monitoring strategies

Precision is adept in the distinct demands of early and late-phase clinical trials, particularly within the realms of Oncology and Rare Disease research. Each phase carries unique monitoring considerations, such as the intensive oversight required during the initial dosing of Phase I studies. Precision tailors monitoring approaches to your trial's design, collaborating with you to determine the monitoring intensity required for optimal data quality and cost-efficiency.

SDV Scenarios
Risk-based Monitoring
Centralized Monitoring

Tailored Source Data Verification Approaches

Precision recognizes that a one-size-fits-all approach does not apply when it comes to Source Data Verification (SDV). Depending on the design and phase of your trial, different SDV strategies—be it 100%, reduced or targeted SDV—can be implemented to maximize data quality while optimizing the allocation of monitoring resources. With our nuanced understanding, we craft SDV monitoring plans that support the depth of data scrutiny required, whether that involves comprehensive verification or a targeted review aligned with specific data risks and study endpoints. By selecting the most suitable SDV method, Precision enhances the integrity of your data and the efficiency of your trial monitoring.
Enhancing Clinical Oversight with Risk-Based Monitoring

At Precision, we embrace a data-centric approach to Risk-Based Monitoring (RBM). By identifying the critical data and how it is collected, we identify potential risks and develop robust strategies to proactively secure the data, enabling our CRAs to focus their efforts where it's most needed. This method not only streamlines the monitoring process but also allocates resources more effectively so that critical trial aspects receive the attention required without undue expenditure. Utilizing advanced analytical tools, such as Precision's Clarity alongside industry-standard platforms like Medidata CTMS, our RBM strategies are designed to safeguard the integrity of your trial data while optimizing the monitoring workload.
Enhanced Centralized Monitoring with Precision

Precision's Centralized Monitoring team leverages our proprietary Clarity clinical intelligence suite to provide a comprehensive review of aggregate data, identifying outliers, trends, and safety signals. Our strategic approach reduces the need for frequent onsite visits by utilizing powerful analytics and dynamic data visualization, augmented by our cross-functional and integrated data review process. This enables Precision to optimize site performance and data integrity, supporting a streamlined SDV/SDR strategy.

Explore

I recognize that relations between Sponsors and CRO vendors can be strained and difficult, often a blaming game; this has never been my experience with this group as it truly felt like a partnership.

— Director, Small Biotech
At so many levels, the Precision for Medicine team has been fantastic. I am very grateful for how responsive and how collaborative the whole team is. Very grateful for their help.

— Director, Midsize Biotech
Precision is part of our team. They put in long days and hard work to help our study to move forward. We are so appreciative of how fast they worked.

— Senior Manager, Clinical Trials, Midsize Biotech
Our partnership with Precision is a true textbook definition of a great collaboration between a sponsor and a CRO.

— Senior Director, Midsize Biotech

Transforming clinical trials through patient centricity

The emphasis on patient centricity and decentralized clinical trials (DCTs) is more than a trend—it’s a transformative shift towards respecting and accommodating the real-world contexts of patients and their caregivers. Precision for Medicine champions this shift, drawing from our rich experience across oncology and rare diseases, to design trials that are as considerate as they are scientifically rigorous. By thoughtfully incorporating patient lifestyles and symptoms into trial designs, we ensure participation is not only viable but also meaningful for patients and caregivers alike. Our strategies embody our commitment to making trials more patient-centric, from pediatric to adult populations, offering a smoother and more inclusive research journey. Discover how our innovative approaches in patient recruitment (HL) and DCTs (HL) are making a difference.

Experts in Complex Diseases and Advanced Therapies

We recognize the patient journey throughout the development process. Our mission is to assist our partners in delivering innovative treatments to patients. Leverage our deep expertise in these therapeutic areas to advance your clinical goals.

Oncology Explore

Rare diseases Explore

Autoimmune Explore

Gene Therapy Explore

Cell Therapy Explore

Precision insights in Clinical Monitoring and beyond

Stay at the forefront of research with Precision’s blog, featuring key updates and insights on clinical monitoring, case studies, and more

Explore Our Blog

Clinical Trials

Advancing Diversity in Oncology Clinical Trials: 5 Key Insights from Clinical Trial Sites

Jan 20, ‘25 | 5 min read

has not third author: true, (SizeLimitingPyMap: {main={hs_id=184750975030, hs_child_table_id=0, hs_updated_at=1736962069119, hs_published_at=1736962071401, description=Melanie Morris brings over two decades of experience in pivotal roles supporting Phase I to IV clinical trials within Site, CRO and Sponsor organizations. As Associate Director of the Precision Site Network at Precision for Medicine, Melanie is dedicated to fostering collaborative, mutually beneficial partnerships with clinical research sites, transforming transactional relationships into enduring alliances that drive shared success.   With a career spanning leadership in clinical operations, functional service provider models, and decentralized trial execution, Melanie has consistently delivered innovative strategies that enhance site engagement and operational excellence. Passionate about creating impactful collaborations, Melanie aims to advance the clinical research landscape and support the development and acceleration of life-changing rare disease and oncology therapies., avatar=Image{width=1218,height=1218,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Melanie%20Morris.jpg',altText='Melanie Morris',fileId=184761298465}, lastname=Morris, hs_initial_published_at=1736540185270, hs_created_by_user_id=26433386, hs_created_at=1736527212397, hs_is_edited=false, hs_deleted_at=0, name=Melanie, job=Associate Director, Precision Site Network, slug=melanie-morris, hs_updated_by_user_id=26433386}, second={hs_id=178046423372, hs_child_table_id=0, hs_updated_at=1725972626778, hs_published_at=1736962071401, description=Rosamund (Roz) Round is a seasoned expert in patient engagement and innovation bringing over 20 years of experience. She is focused on listening to and learning from patients and care partners to understand how to better improve trial access and experience. Roz successfully built and led decentralized clinical trials service through the pandemic and is now addressing the implementation of AI across various aspects of clinical research. She has a strong focus on diversity, equity, and inclusion (DEI) to drive health equity in clinical research. Roz holds an MSc in Health Psychology, studied Psychology and Immunology at Harvard University, and is a recognized thought leader with an extensive portfolio of publications, conference presentations, webinars, and vlogs., avatar=Image{width=600,height=600,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Round%20Rosamund.jpg',altText='Round Rosamund',fileId=177993009992}, lastname=Round, hs_initial_published_at=1725972637852, hs_created_by_user_id=51739740, hs_created_at=1725972446462, hs_is_edited=false, hs_deleted_at=0, name=Rosamund, job=Vice President, PAtient Engagement & Innovation, slug=rosamund-round, hs_updated_by_user_id=51739740}, third={}})

Melanie M.
Rosamund R.

Discover

Clinical Trials

Top Functional Service Providers (FSPs) in Clinical Research for 2025

Jan 15, ‘25 | 8 min read

Rob Maiale

Discover

Clinical Trials

Clinical Trial Trends: Non-malignant Hematology

Jan 13, ‘25 | 4 min read

Jen Vance

Discover

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.

Discover Explore

Global CRO
Services

Award-winning CRO with deep oncology and rare disease expertise

Explore
Discover Explore

Global Laboratory
Services

Exceptional translational and biomarker sciences with global central lab services

Explore
Discover Explore

Manufacturing
Solutions

Pioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.

Explore